Symptomtext
supposed to receive PENTACEL yesterday, but was accidentally given the HIB component with no reported AE; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 4 months old female patient who was supposed to receive pentacel yesterday, but was accidentally given the hib component with no reported ae while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE (PNEUMOCOCCAL VACCINE) for Prophylactic vaccination; and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for Prophylactic vaccination. On 25-Oct-2022, the patient received 0.5 mL of dose 2 of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE (formulation and strength not reported; lot UJ684AAA) via intramuscular route in the intramuscular thigh for prophylactic vaccination. On 25-Oct-2022, (latency: same day) the patient was supposed to receive pentacel yesterday, but was accidentally given the hib component with no reported ae (product preparation error) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE. It was reported, a four month old baby was supposed to receive PENTACEL yesterday, but was accidentally given the HIB component mixed with sterile diluent instead of the DTAP and POLIO component. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.